Drug Trial Radar · NCT03079388
Nutritional and Anti-infective Interventions for Malnutrition in Pregnancy (Beleuman Welbodi)
Last checked: Nov 19, 2026Latest source record: Jan 7, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,489
Actual
Start
Feb 27, 2017
Primary completion
Sep 24, 2019
Study completion Feb 24, 2020
Sponsor
- Lead sponsor
- Washington University School of MedicineAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- The Children's Investment Fund Foundation
- First posted
- Mar 14, 2017
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- Female only, from 14 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Acute malnutrition in pregnancy is a risk factor for adverse outcomes in mothers and their unborn children. Undernutrition during pregnancy can result in maternal complications such as life-threatening hemorrhage and hypertensive disorders of pregnancy and infant complications such as intrauterine growth retardation, low birth weight, pre-term delivery and poor cognitive development. Poor women in the developing world are at heightened risk of malnutrition due to inadequate dietary intake and are subject to transmission of a number of infections including malaria, intestinal helminths, and genitourinary infections. Food interventions for malnutrition may be less effective under conditions with excessive inflammation and infection, and especially so during pregnancy. Without specifically addressing treatment for infections, undernourished mothers may be less responsive to nutritional interventions. The benefits of treating both malnutrition and common infections simultaneously remain largely unstudied. This study tests the hypothesis that malnourished pregnant women receiving 100 grams per day of a specially formulated ready-to-use supplementary food in addition to a combination of 5 anti-infective interventions will have greater weight gain in pregnancy and deliver larger, longer infants than women receiving the standard of care. The outcome of the pregnancy and maternal nutritional status will be followed until 6 months after delivery.
Conditions
- Pregnancy
- Malnutrition in Pregnancy
- Nutrition Disorders
- Stunting
Interventions
Ready-to-use-supplementary foodDietary supplement
Specially formulated supplementary food for pregnancy
Corn-soy-blendDietary supplement
Standard of care for malnutrition in pregnancy in Sierra Leone
Monthly intermittent preventive treatment of malaria during pregnancy (IPTp)Drug
Sulfadoxine-pyrimethamine (500 mg / 25 mg) given every 4 weeks, beginning at enrollment or at 13 weeks' gestation, whichever is later.
Standard intermittent preventive treatment of malaria during pregnancy (IPTp)Drug
Standard of care for Sierra Leone is 2 doses of sulfadoxine/ pyrimethamine (500mg/ 25mg).
Insecticide-treated mosquito netOther
An insecticide-treated mosquito net at the time of enrollment into the study.
AzithromycinDrug
Azithromycin 1 gram given once in second trimester and again during weeks 28-34 of gestation.
AlbendazoleDrug
Single dose albendazole 400mg given in the second trimester.
Bacterial vaginosis testing and treatmentCombination product
Testing for bacterial vaginosis at enrollment and again at weeks 28-34 using a rapid diagnostic test for sialidase. Those with positive tests will receive extended release metronidazole 750mg daily for 7 days.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Infant birth lengthTime frame: up to 40 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
1 Moriba Street
Pujehun, Pujehun District, Sierra Leone
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.